ImmPACT-Bio USA, Inc is a cutting-edge biotechnology company based in Camarillo, CA, specializing in the development of logic-gated cell therapies for unmet medical needs. Their innovative platforms, including bispecific chimeric antigen receptor (CAR) T cells and iCAR technology, aim to prevent antigen escape, overcome the immunosuppressive tumor environment, and potentially cure autoimmune diseases.
Co-founded by pioneering scientists Yvonne Y. Chen, Ph.D., and Antoni Ribas, M.D., Ph.D., ImmPACT-Bio is at the forefront of advancing the next generation of cell therapies. With a focus on addressing key biological challenges in treating grievous diseases, their groundbreaking technologies have the potential to revolutionize oncology treatments and improve patient outcomes.
Generated from the website